Pancreatitis Trial, Recruiting NCT04743479 Sponsor: Changhai Hospital Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT04743479
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing and able to give your agreement to take part and sign a consent form.
  • You (or someone authorized to speak for you) are willing to fill out a detailed questionnaire.
  • You have been recently diagnosed with diabetes (within the last 3 years).
  • You have a family history of pancreatic cancer.
  • You have an inherited condition that is linked to a higher risk of pancreatic cancer, such as Hereditary Pancreatitis, Familial Atypical Multiple Mole and Melanoma Syndrome, Hereditary Nonpolyposis Colon Cancer, Peutz-Jeghers Syndrome, or Hereditary Breast and Ovarian Cancer Syndrome (confirm with trial site if unsure whether your condition qualifies).
  • You have been found to have certain types of fluid-filled cysts on your pancreas (such as IPMN or MCN).
  • You have long-term inflammation of the pancreas (chronic pancreatitis).

Who may not be able to join:

  • You have been diagnosed with pancreatic cancer or any other type of cancer in the last 5 years.
  • You have a health condition that means it would not be safe for you to have a high-detail MRI or CT scan (confirm with trial site).
  • You are not able to attend follow-up appointments, or you are already taking part in another clinical trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gang Jin, M.D., Department of general surgery, Changhai Hospital

Phone: 13774238083

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Changhai Hospital
Registry
ClinicalTrials.gov
Start date
1 December 2020
Est. completion
30 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence; Hazard ratio (HR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov